NCT07404865Phase 3Recruiting

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Study sponsor: Vor Biopharma

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-12Estimated
Enrollment · participants250Estimated
Source updated2026-10-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jun 2028. After: Dec 2028.

Check registry source

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source